Gauraangana Trade Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Gauraangana Trade Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $206.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Gauraangana Trade Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $206.9K Trade | TransData Nexus

Gauraangana Trade Private Limited

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $206.9K Total Trade · DGFT Verified

Gauraangana Trade Private Limited is an Indian pharmaceutical exporter with a total trade value of $206.9K across 2 products in 1 therapeutic categories. Based on 28 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Dettol ($173.5K), Iodex ($33.4K), .

Gauraangana Trade Private Limited — Export Portfolio & Destination Treemap

Gauraangana Trade Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Gauraangana Trade Private Limited? — Company Overview & Market Position

Gauraangana Trade Private Limited, established on February 23, 2004, is a private limited company headquartered in New Delhi, India. The company is registered under the Corporate Identification Number (CIN) U51909DL2004PTC124792. Its authorized capital stands at ₹2.00 million, with a paid-up capital of ₹0.85 million. The registered office is located at 1851 Khari Baoli, New Delhi, Delhi, 110007.

Gauraangana Trade Private Limited operates in the wholesale trade and commission trade sector, excluding motor vehicles and motorcycles. The company is unlisted and has been active for over two decades. As of the latest available data, the company is led by two directors: Sandeep Goel and Sanjay Goel.

What Does Gauraangana Trade Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Dettol$173.5K 2Iodex$33.4K

Product Portfolio — Top 2 by Export Value

Gauraangana Trade Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Dettol	Brand Names & OTC Products	$173.5K	22	2.0%	11
2	Iodex	Brand Names & OTC Products	$33.4K	6	0.5%	6

Gauraangana Trade Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $206.9K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Gauraangana Trade Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding Gauraangana Trade Private Limited's manufacturing facilities are not publicly disclosed. The company's export data indicates a focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. However, without explicit information on manufacturing locations and capacities, a comprehensive analysis cannot be provided.

3Key Leadership

The key executives of Gauraangana Trade Private Limited are:

Sandeep Goel: Director since February 23, 2004.
Sanjay Goel: Director since February 23, 2006.

No additional information regarding other key executives is available in the public domain.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Gauraangana Trade Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Gauraangana Trade Private Limited's export data from 2022 to 2026 indicates shipments totaling $207,000 across 28 transactions, primarily involving finished pharmaceutical formulations. The top exported products include Dettol and Iodex, with market shares of 2.0% and 0.5%, respectively. However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. Without explicit information on regulatory approvals and market access, a detailed analysis cannot be provided.

2Emerging Markets

Gauraangana Trade Private Limited's export data does not specify shipments to Africa, Latin America, or Southeast Asia. The company's focus appears to be on finished pharmaceutical formulations, including products like Dettol and Iodex. Without explicit information on shipments to these regions or WHO prequalification status, a comprehensive analysis cannot be provided.

3Geographic Strategy

The export data indicates that Gauraangana Trade Private Limited's portfolio is entirely concentrated on two products: Dettol and Iodex, accounting for 100% of its exports. This suggests a high level of concentration risk. Without information on the company's strategic direction or diversification efforts, a detailed assessment of its geographic strategy cannot be provided.

Gauraangana Trade Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Gauraangana Trade Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. Without explicit information on these aspects, a comprehensive analysis of the company's FDA status cannot be provided.

2WHO & EU GMP

There is no publicly available information regarding Gauraangana Trade Private Limited's WHO prequalification status, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. Without explicit details on these certifications, a thorough assessment cannot be conducted.

3CDSCO & Indian Regulatory

Specific information regarding Gauraangana Trade Private Limited's Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) is not publicly available. Without explicit details on these regulatory aspects, a comprehensive analysis cannot be provided.

Gauraangana Trade Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Gauraangana Trade Private Limited's export data indicates a focus on finished pharmaceutical formulations, including products like Dettol and Iodex. However, without information on the company's competitors in overlapping categories, market share comparisons, or head-to-head analyses, a detailed competitive landscape assessment cannot be provided.

2Key Differentiators

Gauraangana Trade Private Limited's export data highlights a concentration on two products: Dettol and Iodex. Without information on the company's unique strengths, competitive advantages, or product portfolio distinctions, a comprehensive analysis cannot be provided.

3Strategic Position

The export data indicates that Gauraangana Trade Private Limited's portfolio is entirely concentrated on two products, suggesting a high level of concentration risk. Without information on the company's strategic direction, such as a focus on generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services, a detailed assessment of its strategic position cannot be provided.

Buyer Due Diligence Brief — Evaluating Gauraangana Trade Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Gauraangana Trade Private Limited's export data indicates a focus on finished pharmaceutical formulations, including products like Dettol and Iodex. However, without information on the company's overall track record, export volume consistency, or reliability indicators, a comprehensive supplier assessment cannot be conducted.

2Certifications to Verify

Importers should verify the following certifications when considering Gauraangana Trade Private Limited as a supplier:

FDA Registration: Confirm the company's FDA facility registration status.
WHO-GMP Certification: Verify the company's compliance with World Health Organization Good Manufacturing Practice standards.
EU GMP Certification: Ensure the company holds valid European Union Good Manufacturing Practice certificates.
ISO Certification: Check for relevant ISO certifications indicating quality management systems.

Frequently Asked Questions — Gauraangana Trade Private Limited

How many pharmaceutical products does Gauraangana Trade Private Limited export from India?

Gauraangana Trade Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Dettol ($173.5K), Iodex ($33.4K). Total export value is $206.9K.

What is Gauraangana Trade Private Limited's total pharmaceutical export value?

Gauraangana Trade Private Limited's total pharmaceutical export value is $206.9K, based on 28 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Gauraangana Trade Private Limited cover?

Gauraangana Trade Private Limited exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 2 products).

Get Full Gauraangana Trade Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.